Overview

Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of Adalimumab in uveitis.
Phase:
Phase 2
Details
Lead Sponsor:
Oregon Health and Science University
Collaborators:
The Cleveland Clinic
University of Illinois at Chicago
Treatments:
Adalimumab